TickerFactsScreenerDevelopers

ROCKET PHARMACEUTICALS, INC. (RCKT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2013: $12.79M2014: $3.62M2015: $80.04M2016: $29.80M2017: $18.14M2018: $111.36M2019: $185.38M2020: $297.10M2021: $232.69M2022: $140.52M2023: $55.90M2024: $163.63M2025: $77.56M$77.56M
2013Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$77.56M-52.6%
2024$163.63M+192.7%
2023$55.90M-60.2%
2022$140.52M-39.6%
2021$232.69M-21.7%
2020$297.10M+60.3%
2019$185.38M+66.5%
2018$111.36M+513.8%
2017$18.14M-39.1%
2016$29.80M-62.8%
2015$80.04M+2112.3%
2014$3.62M-71.7%
2013$12.79M—